Investec Bank plc has filed a public dealing disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The disclosure identifies Investec Bank as an exempt principal trader acting in a client-serving capacity with recognised intermediary status under the Code.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status to the company named in the filing.
The dealings were undertaken on 8th July 2026, with the formal disclosure dated 9th July 2026, submitted in compliance with regulatory requirements.
On the purchase side, Investec Bank acquired 1,490,908 ordinary shares in Advanced Medical Solutions Group, with prices ranging from 278p to 279.1p per unit.
Sales activity was also recorded, with 1,582,591 ordinary shares sold at prices ranging from 278p to 279.5p per unit during the same dealing period.
The volume of shares sold exceeded purchases, reflecting active market-making activity consistent with the firm’s role as an exempt principal trader serving clients.
No cash-settled derivative transactions, stock-settled derivatives, or options were reported as part of this disclosure filing.
Investec confirmed that no indemnity arrangements, option agreements, or understandings existed that could serve as an inducement to deal or refrain from dealing with any party to the offer.
The firm also confirmed no agreements relating to voting rights or future acquisition and disposal of relevant securities tied to any derivative instrument.
The contact named in the filing is Abhishek Gawde, reachable by telephone for any follow-up enquiries related to the disclosure.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service to ensure full market transparency.
